Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
1.900
+0.080 (4.40%)
May 13, 2025, 4:00 PM - Market closed
Elutia Employees
Elutia had 51 employees as of December 31, 2024. The number of employees decreased by 3 or -5.56% compared to the previous year.
Employees
51
Change (1Y)
-3
Growth (1Y)
-5.56%
Revenue / Employee
$464,922
Profits / Employee
-$782,118
Market Cap
77.64M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51 | -3 | -5.56% |
| Dec 31, 2023 | 54 | -110 | -67.07% |
| Dec 31, 2022 | 164 | -12 | -6.82% |
| Dec 31, 2021 | 176 | 13 | 7.98% |
| Dec 31, 2020 | 163 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELUT News
- 3 days ago - Elutia Inc. (ELUT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales - GlobeNewsWire
- 12 days ago - Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio - GlobeNewsWire
- 13 days ago - Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025 - GlobeNewsWire
- 21 days ago - Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29 - GlobeNewsWire
- 23 days ago - Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice - GlobeNewsWire
- 4 weeks ago - Elutia Confirms No Material Impact from Global Tariffs - GlobeNewsWire
- 5 weeks ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire